Chandra Bhagat Pharma Fund Raise of ₹29.04 Cr

Chandra Bhagat Pharma Board Meeting Date

Chandra Bhagat Pharma Limited has intimated a board meeting on 13 November 2026 to consider unaudited standalone half-yearly financial results for the period ended September 2026. The trading window closes from 1 October to 16 November 2026.

Chandra Bhagat Pharma Convertible Warrants

Chandra Bhagat Pharma allotted 50 lakh convertible warrants worth ₹21.90 Crore to seven promoter group members. Allotment was completed on 22 October 2026.

Value

₹21.90 Cr

Chandra Bhagat Pharma Convertible Warrants

Chandra Bhagat Pharma allotted 66 lakh convertible warrants at Rs.44 each, raising Rs.7.26 Crore from 9 allottees. Warrants are convertible 1:1 into equity shares within 18 months.

Value

₹7.26 Cr

Chandra Bhagat Pharma Other Announcement

Chandra Bhagat Pharma Ltd filed a certificate for non-applicability of corporate governance requirements for the September 2026 quarter. This exemption applies to SME-listed entities.

Chandra Bhagat Pharma Preferential Issue

Chandra Bhagat Pharma received BSE in-principle approval for a preferential issue of 66,00,000 warrants at Rs. 44 each. Total issue value is approximately Rs. 2.90 Crore.

Value

₹2.90 Cr

Chandra Bhagat Pharma Management Change

Ms. Rajani Dawani has resigned from her position as Company Secretary and Compliance Officer of Chandra Bhagat Pharma Limited, effective September 30, 2026.

SML Mahindra Fund Raise of ₹1,450 Cr

SML Mahindra announced a board-approved rights issue of fully paid-up equity shares at Rs. 10 face value for up to Rs. 1450 Crore. Terms, record date and regulatory approvals remain pending.

Value

₹1,450 Cr

Richa Info Systems Fund Raise of ₹50 Cr

Richa Info Systems board approved raising funds up to ₹50 crore, with mode, terms and instruments yet to be finalised. Investors should await the detailed fundraising terms.

Value

₹50.00 Cr

S J Logistics (India) Fund Raise of ₹92.58 Cr

SJ Logistics' board approved a preferential issue of equity shares and warrants at Rs.326 each, raising about Rs.92.58 Crore. Shareholder approval is sought at an EGM on 7 December 2026.

Value

₹92.58 Cr

Flywings Simulator Training Centre Fund Raise of ₹73.2 Cr

Flywings approved preferential issue of up to 29,87,760 warrants at Rs 245, aggregating Rs 73.20 crore. Shareholder approval is sought at an EGM on November 27, 2026.

Value

₹73.20 Cr

Upsurge Investment & Finance Fund Raise of ₹20 Cr

Upsurge Investment & Finance approved unaudited Q2 FY27 results, appointed Manish Kabra as CFO, and approved raising up to Rs.20 Crore. The raise needs shareholder and regulatory approvals before proceeding.

Value

₹20.00 Cr

Optiemus Infracom Fund Raise

Optiemus Infracom's board approved a fund raise, with mode and amount yet undecided. Details will follow after finalisation.